Gloriosa Superba: Anti-Venom Potential, Phytochemical, Pharmacological Activities and Safety – A Review

Gloriosa superba L., commonly known as "flame lily" or "glory lily," is a perennial climber of the family Colchicaceae, distributed across tropical Africa and parts of Asia. This species has served for centuries in traditional medicine - especially in Africa and the Indian subcontinent- for treating ailments ranging from gout, arthritis, and skin disorders to snakebite, wounds, and gynecological issues. Modern phytochemical investigations reveal that G. superba contains several bioactive alkaloids (notably Colchicine, gloriosine, thiocolchicine) along with non- alkaloidal constituents (flavonoids, sterols, etc.), which contribute to its anti-inflammatory, analgesic, antimicrobial, antioxidant, antimitotic (cytotoxic/anticancer), anthelmintic, and other pharmacological properties. Several in vitro and in vivo studies confirm these effects, especially the anti-inflammatory and cytotoxic activities, which underlie its use in gout, arthritis, and efforts toward anticancer research. However, the plant is highly toxic, and documented cases of severe poisoning-even fatal-underscore the risk associated with unregulated or crude use. Given the therapeutic potential coupled with substantial toxicity, G. superba demands standardized extraction, careful dosage control, and rigorous toxicological and clinical evaluation. This review/article synthesizes existing knowledge on botanical description, phytochemistry, pharmacological effects, traditional and current medicinal uses, extraction methods, and safety considerations - aiming to guide future research and rational therapeutic exploitation of this potent but dangerous medicinal plant.